“…As a consequence, SARS-CoV-2-positive donors are not considered eligible for donation and therefore postponed, or a risk-benefit ratio must be balanced to decide to proceed anyway to HSC collection. We recently reported our experience during the first wave of Covid-19 when we found a 6% (1 out of 17 donors) prevalence among stem cell donors [1] ; other groupd reported cases of HSC collections from positive donors, who had a regular clinical course after donation [2] , [3] , [4] and, importantly, did not transmit the infection by the means of HSC donation, as also is expected with blood donations [5] , [6] .…”